Champions Oncology Inc. (NASDAQ: CSBR) Stock Information | RedChip
Image

ASK REDCHAT ANYTHING ABOUT CHAMPIONS ONCOLOGY INC.

Champions Oncology Inc. (NASDAQ: CSBR)
Listen to this Section


$5.67
-0.0950 ( -1.65% ) 0.4K

Champions Oncology Inc is a USA based company which is engaged in the development and sale of advanced technology solutions and products to personalize the development and use of oncology drugs. The company operates through one segment namely Personalized Oncology Solutions (POS) and Translational Oncology Solutions (TOS). Its POS business assists physicians in developing personalized treatment options for their cancer patients through tumor specific data obtained from drug panels and related personalized oncology services. The TOS business assists pharmaceutical and biotechnology companies with their drug development process and offers studies or license tumors for use in studies. They derive revenue primarily from research services.

Market Data


Open $5.67
Previous Close $5.76
Volume 0.4K
Market Cap $79.02M
Day Range $5.67 - $5.78
52 Week Range $5.50 - $9.63
Shares Outstanding 13.89M
Change % -1.65%
Net Change ▼ -0.0950
Insider Ownership -0.02%
Exchange NASDAQ
SectorHealthcare
IndustryBiotechnology: Biological Products (No Diagnostic Substances)
IPO Year1994
CountryUnited States

Insider Ownership Transactions

Total Amount Purchased: -385,698.00

Date Type Amount Purchased Purchaser
2024-04-01 Sale -135000.00 Davis Brady
2024-01-16 Buy 1000.00 Mendelson Daniel Newman
2024-01-12 Buy 2000.00 Mendelson Daniel Newman
2024-01-11 Buy 2944.00 Mendelson Daniel Newman
2024-01-10 Buy 3000.00 Mendelson Daniel Newman
2024-01-09 Buy 1000.00 Mendelson Daniel Newman
2024-01-08 Buy 3000.00 Mendelson Daniel Newman
2024-01-08 Buy 2000.00 Mendelson Daniel Newman
2024-01-05 Sale -114552.00 ACKERMAN JOEL
2024-01-04 Buy 500.00 Mendelson Daniel Newman

SEC Filings


Form Type Description Pages Date
10-k Annual reports 78 Jul 23, 2025
8-k 8K-related 15 Jul 23, 2025
8-k 8K-related 16 Jul 21, 2025

Latest News


× Before browsing our site, please accept our cookies policy